Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
BMJ Open|January 29, 2016
Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall interventionN Bayman, D Ardron, L Ashcroft, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 30, 2023
[Real world data in radiotherapy: A data farming project by Unitrad]S Guihard, M Piot, I Issoufaly, et al.
Journal of Medical Imaging and Radiation Sciences|August 17, 2024
Simultaneous implementation of unrelated tumour sites on the MR Linac: A review of the commissioning process from a radiographer perspective and lessons learnedA Clough, E Pitt, C Nelder, et al.
BMC Medical Education|January 17, 2018
Choosing a career in oncology: results of a nationwide cross-sectional studyJ C Faivre, J E Bibault, A Bellesoeur, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 17, 2022
Impact of radiotherapy on survival in resected or unresectable anaplastic thyroid carcinomas, a Rare Cancer Network studyX S Sun, J Le Guevelou, J Jacquemin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 20, 2026
Patient Perspectives on Reirradiation for Recurrent Cancer, to Inform Future Clinical Trial DesignF Slevin, S Kendal, A L Appelt, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 26, 2020
Predicting the Risk of Disease Recurrence and Death Following Curative-intent Radiotherapy for Non-small Cell Lung Cancer: The Development and Validation of Two Scoring Systems From a Large Multicentre UK CohortM Evison, E Barrett, A Cheng, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 1, 2020
Palliative Lung Radiotherapy: Higher Dose Leads to Improved Survival?T S Lewis, J A Kennedy, G J Price, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 17, 2021
Neutrophil-Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung CancerA Punjabi, E Barrett, A Cheng, et al.
ESMO Open|May 28, 2025
Durvalumab after sequential chemoradiotherapy in unresectable stage III non-small-cell lung cancer-final analysis from the phase II PACIFIC-6 trialM C Garassino, J Khalifa, M Reck, et al.
Pageof 14